Dixon Hubard Feinour & Brown’s Humana HUM Stock Holding History

Dixon Hubard Feinour & Brown’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$221K	Hold	472	–	–	0.03%	263
2022 Q1	$205K	Hold	472	–	–	0.02%	293
2021 Q4	$219K	Buy	+472	New	+$209K	0.02%	284

Other funds holding HUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dixon Hubard Feinour & Brown's HUM Position: Q2 2022 in Review

Dixon Hubard Feinour & Brown held its Humana (HUM) position steady in Q2 2022 at 472 shares worth $221K. The position accounts for 0.03% of the portfolio, ranked #263.

Dixon Hubard Feinour & Brown first reported a position in HUM in Q4 2021 and has held it in 3 quarters since. 959 funds tracked by Wall St. Rank hold HUM as of Q2 2022.

Dixon Hubard Feinour & Brown held 472 shares of Humana worth $221K as of Q2 2022.
Dixon Hubard Feinour & Brown left its Humana share count unchanged in Q2 2022.
Humana made up 0.03% of Dixon Hubard Feinour & Brown's portfolio in Q2 2022, its #263 holding.
Dixon Hubard Feinour & Brown first reported a position in Humana in Q4 2021 and has held it in 3 quarters since.
959 funds tracked by Wall St. Rank held Humana as of Q2 2022.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q2 2022, filed 22 Jul 2022.